• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Molecular analysis of the mechanism of abnormal immune functions in Behcet's diseases

Research Project

Project/Area Number 10670430
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field 内科学一般
Research InstitutionTeikyo University

Principal Investigator

HASHIMOTO Takashi  Teikyo University, School of Medicine, Associate Professor, 医学部, 助教授 (30082142)

Co-Investigator(Kenkyū-buntansha) YANAGIDA Tamiko  Teikyou University, School of Medicine, Assistant, 医学部, 助手 (80082204)
MIYASHITA Taku  Teikyou University, School of Medicine, Assistant, 医学部, 助手 (00239401)
HIROHATA Shunsei  Teikyou University, School of Medicine, Associate Professor, 医学部, 助教授 (90189895)
Project Period (FY) 1998 – 1999
Project Status Completed (Fiscal Year 1999)
Budget Amount *help
¥3,100,000 (Direct Cost: ¥3,100,000)
Fiscal Year 1999: ¥1,300,000 (Direct Cost: ¥1,300,000)
Fiscal Year 1998: ¥1,800,000 (Direct Cost: ¥1,800,000)
KeywordsT lymphocytes / CD3 / T cell receptor / two-dimensional gel electrophoresis / neutrophil / actin / cerebrospinal fluid / IL-6 / SEC1 / 固相化抗CD3抗体 / IFN-γ / ベーチェット病 / T細胞 / スーパー抗原 / Stapylococcal enterotoxins / T細胞抗原レセプター
Research Abstract

First, this study examines the nature of T cell hypersensitivity in Behcet's disease (BD). The results confirm that T cell hypersensitivity is not confined to certain specific antigens in BD. More importantly, the data strongly suggest that abnormalities in signal transduction triggered by perturbation of T cell receptors, but not in that induced by cross-linking of CD3 molecules nor in that delivered through costimulation molecules, play an important role in the pathogenesis of BD.
Second, to delineate the mechanism of hyperfunction of neutrophils in BD, protein changes in neutrophils of patents with BD were analyed by high resolution two-dimensional gel electrophoresis. Two clear protein spots were found to be differently expressed between healthy volunteers and patents with BD. One was a 53 kDa protein with pI 5.2 that was detected in healthy volunteers but nearly absent in the patients. The other was a 40 kDa protein with pI 5.2 that was detected in the patents but nearly absent in healthy volunteers. Analysis of N-terminal amino acid sequence of the 40 kDa protein revealed that it was a truncated actin with an N-terminus of Met-44. The presence of the truncated actin in the neutrophils of patients was confirmed by a western blot analysis using an antibody to the C-terminus of actin. The presence of the truncated actin in the neutrophils of the patients may be important in understanding the pathology BD.
Lastly, we sought to find out a beneficial treatment for the slowly progressive dementia (progressive NB), which may ultimately lead to the deterioration of the personality of patients with BD. The results suggest that low dose weekly MTX therapy, which could decrease the CSF IL-6 activity, might have a beneficial effect in the treatment of progressive NB, although a trial for longer period would be necessary.

Report

(3 results)
  • 1999 Annual Research Report   Final Research Report Summary
  • 1998 Annual Research Report
  • Research Products

    (32 results)

All Other

All Publications (32 results)

  • [Publications] Hirohata S: "Abnormal T cell responses to bacterial superantigens in Behcet's disease(BD)."Clin Exp Immunol. 112. 317-324 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Hirohata S: "Low-dose weekly methotrexate for progressive neuropsychiatric manifestation in Behcet's disease."J. Neruol Sci. 159. 181-185 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Okai T: "Successful treatment of patient with Neuro-Behcet's disease with low-dose weekly methotrexate."Jpn J Rheumatol. 8. 195-203 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Hirohata S: "Human Th1 responses driven by IL-12 are associated with enhanced expression of CD40 ligand"Clin Exp Immunol. 115. 78-85 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Hirihata S: "Synergistic inhibition of human B cell activation by gold soidum thiomalate and auranofin"Clin Immunol. 91. 226-233 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Hirohata S: "Inhibition of human B cell activation by a novel nonsteroidal antiinflammatory drug, indometacin farnesil."Immunopharmacology. 44. 245-254 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Hirohata S, et al: "Association of serum IgG antibodies to recombinant ribosomal P0 fusion protein and neuropsychiatric systemic lupus erythematosus"Arthritis Rheum. Vo.41. 745-747 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Hirohata S, et al: "Purity of synthrtic ribosomal P peptides in enzyme-linked immunosorbent assay: comment on the article by Yoshio et al."Arthritis Rheum. Vol.41. 1137-1138 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Hirohata S, Hashimoto T: "Abnormal T cell responses to bacterial superantigens in Behcet's disease (BD)."Clin Exp Immunol. Vol.112. 317-324 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Hirohata S, et al: "Low-dose weekly methotrexate for progressive neuropsychiatric manifestations in Behcet's disease."J Neurol Sci. Vol.159. 181-185 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Okai T, et al: "Successful treatment of a patient with Neuro-Behcet's disease with low-dose weekly methotrexate."Jpn J Rheumatol. Vol.8. 195-203 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Isshi K, et al: "Differential roles of the anti-ribosomal P antibody and antineuronal antibody in the pathogenesis of central nervous system involvement in systemic lupus erythematosus"Arthritis Rheum. Vol.41. 1819-1827 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Hirohata S, et al: "Regulation of human B lymphocyte responsiveness by activated CD4+ T cells."Current Trends in Immunology. Vol.1. 43-56 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Hirohata S, et al: "Human Th1 responses driven by IL-12 are associated with enhanced expression of CD40 ligand."Clin Exp Immunol. Vol.115. 78-85 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Hirohata S, et al: "The role of carrier protein in the sensitivity of enzyme-linked immunosorbent assay forantiribosomal P protein antibodies: further comment on the article by Yoshio et al."Arthritis Rheum. Vol.42. 593-594 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Hirohata S, et al: "Suppressive influuences of methotrexate on the generation of CD14(+) monocyte-lineage cells from bone marrow of patient with rheumatoid arthritis."Clin Immunol. Vol.91. 84-89 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Hirohata S, et al: "Angioneogenesis as a possible elusive triggering factor in rheumatoid arthritis."Lancet. Vol.353. 1331 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Hirohata S, et al: "Synergistic inhibition of human B cell activation by gold soidum thiomalate and auranofin"Clin Immunol. Vol.91. 226-233 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Hirohata S, et al: "Angioneogenesis in rheumatoid arthritis. Author's reply"Lancet. Vol.354. 423-424 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Hirohata S, et al: "Inhibition of human B cell activation by a novel nonsteroidal anti-inflammatory drug, indometacin famesil."Immunopharmacology. Vol.44. 245-254 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Shimamoto Y, et al: "Reiter's syndrome associated with HLA-B51"Internal medicine. in press).

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Hirohata S, et al: "Bone marrow CD34+ progenitor cells from rheumatoid arthritis patients support spontaneous transformation of peripheral blood B cells from healthy individuals."Rheumatology International. (in press).

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Yamashita S, et al: "Analysis of neutrophil proteins of patients with Behcet's disease by two-dimensionnal gel elecreophoresis."Biol Pharm Bull. 23(in press).

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Hirohata S: "Low-dose weekly methotrexate for progressive neuropsychiatric manifestations in Behcet's disease"J Neurol Sci. 159. 181-185 (1998)

    • Related Report
      1999 Annual Research Report
  • [Publications] Hirohata S: "Human Th1 responses driven by IL-12 are associated with enhanced expression of CD40 ligand"Clin Exp Immunol. 115. 78-85 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Hirohata S: "Synergistic inhibition of human B cell activation by gold soidum thiomalate and auranofin"Clin Immunol. 91. 226-233 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Hirohata S: "Inhibition of human B cell activation by a novel nonsteroidal antiinflammatory drug,indometacin farnesil"Immunopharmacology. 44. 245-254 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Simamoto Y: "Reiter's syndrome associated with HLA-B51"Internal Medicine. (in press).

    • Related Report
      1999 Annual Research Report
  • [Publications] Yamashita S: "Analysis of neutrophil proteins of patients with Behcet's disease by two-dimensionnal gel elecreophoresis"Biol Pharm Bull. (in press).

    • Related Report
      1999 Annual Research Report
  • [Publications] Hirohata S,Hashimoto T.: "Abnormal T cell responses to bacterial superantigens in Behcet's disease(BD)." Clin Exp Immunol. 112. 317-324 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Hirohata S,Suda H,Hashimoto T.: "Low-dose weekly methotrexate for progressive neuropsychiatric manifestations in Behcet's disease." J Neurol Sci. 159. 181-185 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Okai T,Tadokoro M,Hirohata S.: "Successful treatment of a patient with Neuro-Behcet's disease with low-dose weekly methotrexate." Jpn J Rheumatol. 8. 195-203 (1998)

    • Related Report
      1998 Annual Research Report

URL: 

Published: 1998-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi